Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Bevacizumab|Neoadjuvant Chemotherapy|Molecular Targeted Therapy
Interventions: DRUG: bevacizumab
Sponsor: LiNanlin,Ph.D, Chief Physician,Clinical Professor
Collaborators: Roche Pharma AG